Ignite Creation Date:
2025-12-26 @ 2:41 PM
Ignite Modification Date:
2025-12-26 @ 2:41 PM
Study NCT ID:
NCT00071006
Status:
COMPLETED
Last Update Posted:
2012-06-08
First Post:
2003-10-09
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
AG-013736 (Axitinib) In Patients With Poor Prognosis Acute Myeloid Leukemia (AML) Or Myelodysplastic Syndrome (MDS)
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-09
Start Date Type:
None
Primary Completion Date:
2004-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2004-07
Completion Date Type:
ACTUAL
First Submit Date:
2003-10-09
First Submit QC Date:
None
Study First Post Date:
2003-10-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-02-25
Results First Submit QC Date:
None
Results First Post Date:
2012-03-19
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-05-31
Last Update Post Date:
2012-06-08
Last Update Post Date Type:
ESTIMATED